News, features, and commentary about cancer-related issues
The Oncology Institute (100 clinics, 5 states) disclosed a patient data breach; RSNA flagged new privacy risks from growing AI adoption in radiology. Both incidents confirm that clinical AI rollouts require security-by-design and HIPAA compliance from day one, not as an afterthought.
— News, features, and commentary about cancer-related issues
May 29, 2026
• 1 min read
The FDA issued draft guidance aimed at reducing unnecessary use of animal testing for cancer drugs.
Former U.S. Attorney General Pam Bondi, 60, acknowledged that she has thyroid cancer. (People)
FDA draft guidance aims to reduce animal testing in cancer drug development
Cancer is changing. Is pharma marketing changing with it?
Pharmalittle: We're reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
Ahead of ASCO, all eyes on pancreatic cancer
FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
FDA oncology roundup: AbbVie’s rare cancer approval, AstraZeneca in breast cancer limbo - Pharmaceutical Technology
Pharma urged to modernize patient support as young adult cancer rates rise
At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
Guideline update underscores ‘importance of options’ for colorectal cancer screening
The ‘search for a magic bullet has faded’ in cancer immunotherapy. Here’s what’s next
The FDA has issued draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer…
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
Monitoring trials in real time may help shorten the time interval between trial phases.
The FDA's new path, the status of animal testing, and other biotech news from The Readout
Four cancer drugs have got the FDA nod in May thus far, with approvals spanning haematological and solid tumour indications.
Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report…
